Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
boston blog main
boston top stories
3
×
clinical trials
life sciences
national blog main
biotech
national top stories
new york blog main
new york top stories
access biotechnology
access industries
acorda therapeutics
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
ampyra
anemia
antibiotics
apokyn
apomorphine
atlas ventures
axial spondyloarthritis
bausch health
biogen
blood diseases
blood disorders
boston
boston university
boulder/denver blog main
boulder/denver top stories
brian macdonald
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
What
new
3
×
drug
acorda
advance
anemia
approval
approved
bio
biogen’s
biopharmaceutical
blood
body
carry
cells
companies
convo
cope
disc
disease
earlier
episodes
failures
fda
friday
gets
having
health
help
iron
late
launches
lead
littered
little
looms
lungs
meant
medications
medicine
nash
Language
unset
Current search:
abbvie
×
" boston top stories "
×
new
×
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms